290
Participants
Start Date
October 22, 2013
Primary Completion Date
February 4, 2023
Study Completion Date
February 4, 2023
ladiratuzumab vedotin
LV will be given into the vein (IV; intravenously)
Trastuzumab
Trastuzumab will be given by IV every 3 weeks at a dose of 6 mg/kg (the first dose will be 8 mg/kg)
Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medicine, New York
University of Maryland, Baltimore
West Virginia University, Morgantown
Wake Forest Baptist Medical Center / Wake Forest University, Winston-Salem
Piedmont Cancer Institute, Atlanta
H. Lee Moffitt Cancer Center and Research Institute, Tampa
University of Alabama at Birmingham, Birmingham
Tennessee Oncology-Nashville/Sarah Cannon Research Institute, Nashville
Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland
The Cleveland Clinic, Cleveland
Indiana University Simon Cancer Center, Indianapolis
Karmanos Cancer Institute / Wayne State University, Detroit
Allina Health Cancer Institute, Minneapolis
University of Minnesota, Minneapolis
Mayo Clinic Rochester, Rochester
University of Chicago Medical Center, Chicago
Washington University in St Louis, St Louis
Louisiana State University Health Sciences Center, New Orleans
Texas Oncology - Baylor Sammons Cancer Center, Dallas
Cancer Care Centers of South Texas - HOAST/Texas Oncology, New Braunfels
Rocky Mountain Cancer Centers - Aurora, Aurora
Poudre Valley Health System (PVHS), Fort Collins
Pinnacle Oncology Hematology, Scottsdale
University of New Mexico Cancer Center, Albuquerque
Comprehensive Cancer Centers of Nevada, Las Vegas
Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute, Los Angeles
UCLA Medical Center / David Geffen School of Medicine, Santa Monica
UC San Diego / Moores Cancer Center, La Jolla
University of California at San Francisco, San Francisco
Oregon Health and Science University, Portland
Swedish Cancer Institute, Seattle
Seattle Cancer Care Alliance / University of Washington, Seattle
Northwest Medical Specialties, Puyallup
Yale Cancer Center, New Haven
The Whittingham Cancer Center / Norwalk Hospital, Norwalk
Dana Farber Cancer Institute, Boston
Seagen Inc.
INDUSTRY